C4 Therapeutics (CCCC) Return on Assets (2020 - 2025)
Historic Return on Assets for C4 Therapeutics (CCCC) over the last 6 years, with Q3 2025 value amounting to 0.42%.
- C4 Therapeutics' Return on Assets fell 1500.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.29% for FY2024, which is 400.0% up from last year.
- Latest data reveals that C4 Therapeutics reported Return on Assets of 0.42% as of Q3 2025, which was down 1500.0% from 0.36% recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Return on Assets ranged from a high of 0.17% in Q4 2021 and a low of 0.42% during Q3 2025
- In the last 5 years, C4 Therapeutics' Return on Assets had a median value of 0.29% in 2022 and averaged 0.28%.
- As far as peak fluctuations go, C4 Therapeutics' Return on Assets tumbled by -1700bps in 2023, and later skyrocketed by 1000bps in 2024.
- Quarter analysis of 5 years shows C4 Therapeutics' Return on Assets stood at 0.17% in 2021, then tumbled by -73bps to 0.29% in 2022, then crashed by -31bps to 0.37% in 2023, then rose by 22bps to 0.29% in 2024, then tumbled by -46bps to 0.42% in 2025.
- Its Return on Assets was 0.42% in Q3 2025, compared to 0.36% in Q2 2025 and 0.31% in Q1 2025.